Genetic testing market size expands in UAE

Middle East is showing increased signs of recovery in health care and due to this the UAE genetic testing market size is expected to reach USD 120.82 million by 2030.

According to major market research companies, the genetic testing market is anticipated to expand at a CAGR of 22.2% from 2022 to 2030. The UAE became one of the fastest-growing economies in the world in the mid-twentieth century, with this expansion contributing to economic, sociodemographic, and lifestyle changes in its population.

The incidence of cancer is significant in the UAE, and it is the country’s third-largest cause of noncommunicable diseases (NCD)-related mortality. According to WHO 2020 report, the UAE has a cancer incidence and mortality of 4,807 and 1,896, respectively. The rise in population also brings about an epidemiological increase in NCD rates. The increasing cases of cancer has is also estimated to drive the genetic testing market growth.

The technological advancements in diagnostic equipment have proven to be very useful in preventing, maintaining, and treating genetic diseases. It has also proven to be beneficial in prompt intervention for treating diseases when detected early in infancy through newborn screening. Aside from providing precise and reliable estimates of the prevalence of inherited diseases, molecular genetic testing is playing a vital role in the understanding of genetic disease’s molecular pathology. This analysis is expected to improve prognosis and guide the development of customized molecular diagnostic methodologies against gene-related diseases.

In June 2021, the UAE announced a new first-of-its-kind institution focused on strengthening local genomic research as well as detecting and treating people with genetic abnormalities. This aims to assist in achieving the objective of enhancing health through cutting-edge academic research and the development of future researchers who will serve individuals and organizations in the UAE and around the region. These factors are expected to boost the market growth during the forecast period.

Genetic research & development in the country is playing a vital role in the advancements of personalized medicines. Due to the wide range of applications offered by genetic testing, the authorities are focusing on conducting innovative programs for citizens. For instance, in March 2018, the Dubai authority announced its ambitious plan to test the DNAs of all three million citizens. Increasing support by the government and favorable regulatory policies is anticipated to boost the demand for gene-related testing in the country.

Related Articles

Back to top button